PenderFund Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

PenderFund Capital Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-34,840	Closed	-$877K	–	138
2023 Q3	$877K	Buy	+34,840	New	+$394K	0.26%	61

PenderFund Capital Management's ICPT Position: Q4 2023 in Review

PenderFund Capital Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 34,840 shares — an estimated $877K sold.

PenderFund Capital Management first reported a position in ICPT in Q3 2023 and held it in 1 quarter. The position peaked at $877K in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

PenderFund Capital Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
PenderFund Capital Management sold 34,840 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $877K.
PenderFund Capital Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2023 and held it in 1 quarter.
PenderFund Capital Management's Intercept Pharmaceuticals, Inc. position peaked at $877K in Q3 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on PenderFund Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.